CX Institutional
HALO icon

CX Institutional’s Halozyme HALO Stock Holding History

CX Institutional’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3K Hold
27
– – ﹤0.01% 1506
2026
Q2 		$2K Hold
27
– – ﹤0.01% 1469
2026
Q1 		$2K Buy
+27
New +$1.9K ﹤0.01% 1454

Other funds holding HALO

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Livforsakringsbolaget Skandia
Livforsakringsbolaget Skandia Stockholm, Sweden $3.02B AUM 43.19% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

CX Institutional's HALO Position: Q3 2026 in Review

CX Institutional held its Halozyme (HALO) position steady in Q3 2026 at 27 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1506.

CX Institutional first reported a position in HALO in Q1 2026 and has held it in 3 quarters since. 161 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • CX Institutional held 27 shares of Halozyme worth $3K as of Q3 2026.
  • CX Institutional left its Halozyme share count unchanged in Q3 2026.
  • Halozyme made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #1506 holding.
  • CX Institutional first reported a position in Halozyme in Q1 2026 and has held it in 3 quarters since.
  • 161 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.